Literature DB >> 20071564

Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus.

Xinhui Ge1, Venus Tan, Paul L Bollyky, Nathan E Standifer, Eddie A James, William W Kwok.   

Abstract

Very limited evidence has been reported to show human adaptive immune responses to the 2009 pandemic H1N1 swine-origin influenza A virus (S-OIV). We studied 17 S-OIV peptides homologous to immunodominant CD4 T epitopes from hemagglutinin (HA), neuraminidase (NA), nuclear protein (NP), M1 matrix protein (MP), and PB1 of a seasonal H1N1 strain. We concluded that 15 of these 17 S-OIV peptides would induce responses of seasonal influenza virus-specific T cells. Of these, seven S-OIV sequences were identical to seasonal influenza virus sequences, while eight had at least one amino acid that was not conserved. T cells recognizing epitopes derived from these S-OIV antigens could be detected ex vivo. Most of these T cells expressed memory markers, although none of the donors had been exposed to S-OIV. Functional analysis revealed that specific amino acid differences in the sequences of these S-OIV peptides would not affect or partially affect memory T-cell responses. These findings suggest that without protective antibody responses, individuals vaccinated against seasonal influenza A may still benefit from preexisting cross-reactive memory CD4 T cells reducing their susceptibility to S-OIV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071564      PMCID: PMC2838145          DOI: 10.1128/JVI.02226-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

Authors:  Winfried Barchet; Jeffrey D Price; Marina Cella; Marco Colonna; Sandra K MacMillan; J Perren Cobb; Paul A Thompson; Kenneth M Murphy; John P Atkinson; Claudia Kemper
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

3.  Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus.

Authors:  Michelle Roti; Junbao Yang; DeAnna Berger; Laurie Huston; Eddie A James; William W Kwok
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

4.  Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the Americas.

Authors:  Luke T Daum; Linda C Canas; Catherine B Smith; Alexander Klimov; William Huff; William Barnes; Kenton L Lohman
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

5.  Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects.

Authors:  Junbao Yang; Nancy A Danke; DeAnna Berger; Sandra Reichstetter; Helena Reijonen; Carla Greenbaum; Catherine Pihoker; Eddie A James; William W Kwok
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

6.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

7.  Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans.

Authors:  Erika Assarsson; Huynh-Hoa Bui; John Sidney; Qing Zhang; Jean Glenn; Carla Oseroff; Innocent N Mbawuike; Jeff Alexander; Mark J Newman; Howard Grey; Alessandro Sette
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

8.  Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment.

Authors:  John Steel; Peter Staeheli; Samira Mubareka; Adolfo García-Sastre; Peter Palese; Anice C Lowen
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

9.  Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-22       Impact factor: 17.586

10.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.

Authors:  Laurel Yong-Hwa Lee; Do Lien Anh Ha; Cameron Simmons; Menno D de Jong; Nguyen Van Vinh Chau; Reto Schumacher; Yan Chun Peng; Andrew J McMichael; Jeremy J Farrar; Geoffrey L Smith; Alain R M Townsend; Brigitte A Askonas; Sarah Rowland-Jones; Tao Dong
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

View more
  56 in total

1.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.

Authors:  Hugues de Lavallade; Paula Garland; Takuya Sekine; Katja Hoschler; David Marin; Kate Stringaris; Eva Loucaides; Katherine Howe; Richard Szydlo; Ed Kanfer; Donald Macdonald; Peter Kelleher; Nichola Cooper; Ahmad Khoder; Ian H Gabriel; Dragana Milojkovic; Jiri Pavlu; John M Goldman; Jane F Apperley; Katayoun Rezvani
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

Review 4.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.

Authors:  Leonard Moise; Ryan Tassone; Howard Latimer; Frances Terry; Lauren Levitz; John P Haran; Ted M Ross; Christine M Boyle; William D Martin; Anne S De Groot
Journal:  Hum Vaccin Immunother       Date:  2013-09-17       Impact factor: 3.452

6.  A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge.

Authors:  Timothy D Carroll; Sinthujan Jegaskanda; Shannon R Matzinger; Linda Fritts; Michael B McChesney; Stephen J Kent; Jeffery Fairman; Christopher J Miller
Journal:  J Infect Dis       Date:  2018-08-14       Impact factor: 5.226

7.  The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.

Authors:  Yuk-Fai Lau; Amber R Wright; Kanta Subbarao
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

8.  Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.

Authors:  Anne S De Groot; Elizabeth McClaine; Lenny Moise; William Martin
Journal:  Hum Vaccin       Date:  2010-02-19

9.  Unsupervised capture and profiling of rare immune cells using multi-directional magnetic ratcheting.

Authors:  Coleman Murray; Hiromi Miwa; Manjima Dhar; Da Eun Park; Edward Pao; Jessica Martinez; Sireesha Kaanumale; Evelina Loghin; John Graf; Khadir Raddassi; William W Kwok; David Hafler; Chris Puleo; Dino Di Carlo
Journal:  Lab Chip       Date:  2018-08-07       Impact factor: 6.799

10.  Peptide-MHC cellular microarray with innovative data analysis system for simultaneously detecting multiple CD4 T-cell responses.

Authors:  Xinhui Ge; John A Gebe; Paul L Bollyky; Eddie A James; Junbao Yang; Lawrence J Stern; William W Kwok
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.